Trials / Completed
CompletedNCT00362960
Olmesartan Medoxomil and Diabetic Nephropathy
Effect of Different Doses of Olmesartan Medoxomil Compared to Losartan on Proteinuria, Renal Function and Inflammatory Markers in Type 2 Diabetics With Nephropathy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 300 (planned)
- Sponsor
- Sankyo Pharma Gmbh · Industry
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of several olmesartan dosages compared to losartan on proteinuria, renal function and inflammatory markers in patients with diabetic nephropathy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olmesartan medoxomil | |
| DRUG | Losartan |
Timeline
- Start date
- 2003-05-01
- Completion
- 2004-09-01
- First posted
- 2006-08-15
- Last updated
- 2006-10-09
Locations
27 sites across 7 countries: Czechia, Estonia, Germany, Netherlands, Poland, Slovakia, Spain
Source: ClinicalTrials.gov record NCT00362960. Inclusion in this directory is not an endorsement.